Category: 2017 – 4
Register now
Posted by admin | May 19, 2017 | Uncategorized | 0
“Is that all?” Very little investment needed to sa...
Posted by admin | Sep 17, 2016 | Introduction | 0
Welcome
Posted by admin | Jul 11, 2016 | Introduction | 0
Introduction by Jean Carlet
Posted by admin | Apr 7, 2016 | Government engagement, Introduction | 0
2017
PopularThe role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Dr Christopher Houchens, Branch Chief, Antibacterial Program and Dr Joe Larsen Deputy Director, Division of CBRN Medical Countermeasures, Biomedical Advanced Research and Development Authority, Office of Assistant Secretary for...
-
-
Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back
by admin | Jul 31, 2017 | 2017, Healthcare | 0
-
Research in essential oils: the case of Oregano
by admin | Aug 2, 2017 | 2017, Alternatives to Antibiotics | 0
Economics and Innovation
LatestThe Economics of reducing antibiotic use to reduce antimicrobial resistance
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA Human consumption of antibiotics is only beneficial to societal welfare when the correct antibiotics are used and they are given...
-
-
Socioeconomics, antimicrobial use and antimicrobial resistance
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
-
2017

MedTech Europe

Institut Merieux

Less than one cent to save a patient fro...
A National Action Plan to Contain Antimi...

MedTech Europe

The Global Point Prevalence Survey ̵...

Because taking care is the essence of he...
Healthcare
PopularPotential impact of telemonitoring by connected devices on the evaluation of antibiotic therapy’s duration in the ambulatory treatment of pulmonary infections
by admin | Aug 1, 2017 | 2017, Healthcare | 0
Dr Aurélien Dinh, Infectious Disease Specialist and Dr Clara Duran, Clinical Research Associate, infectious disease unit, raymond poincaré teaching hospital, versailles Saint-Quentin University, Garches, France; and Dr François...
-
-
-
Drug-Resistant Tuberculosis: What Is The Situation, What Are The Needs To Roll It Back?
by admin | Jul 26, 2017 | 2017, Healthcare | 0
Economics and Innovation
Top RatedThe role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Dr Christopher Houchens, Branch Chief, Antibacterial Program and Dr Joe Larsen Deputy Director, Division of CBRN Medical Countermeasures, Biomedical Advanced Research and Development Authority, Office of Assistant Secretary for...
-
-
Socioeconomics, antimicrobial use and antimicrobial resistance
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
-
All
LatestPhage therapy: A promising weapon in the global superbug crisis
Phage therapy: A promising weapon in the global superbug crisis Dr Steffanie Strathdee, Associate Dean of Global Health Sciences, Harold Simon Professor of Medicine and Co-Director, Center for Innovative Phage Applications
- All
- Diagnostics
- Rational use of antibiotics
Phage therapy: A promising weapon in the global superbug crisis
Phage therapy: A promising weapon in the global superbug crisis Dr Steffanie Strathdee, Associate Dean of Global Health Sciences, Harold Simon Professor of Medicine and Co-Director, Center for Innovative Phage Applications
Augmented* medicine for all
by admin | Jul 19, 2016 | Diagnostics, Sponsored features
Fabienne Ostermeyer, International Development Director, Visiomed Group International Imagine if...
-
Diagnostics come of age to combat antimicrobial resistance
by admin | Jul 19, 2016 | Diagnostics, Sponsored features
-
Diagnostic innovation for antimicrobial resistance
by admin | Jul 11, 2016 | Diagnostics
-
Medical value of the rapid MRSA/SA screening in emergency surgery
by admin | Jul 11, 2016 | Diagnostics
The evolution of the global antibiotic resistance partnership
by admin | Sep 12, 2016 | Rational use of antibiotics
Hellen Gelband, Associate Director for Policy, Center for Disease Dynamics, Economics & Policy...
Categories
- 2016 (21)
- 2016 frontpage (4)
- 2017 (37)
- Alternatives to Antibiotics (2)
- Economics and Innovation (4)
- Governance (8)
- Healthcare (8)
- One Health (7)
- Supporters 2017 (6)
- 2017 frontpage (4)
- 2018 frontpage (5)
- 2018 frontpage français (4)
- 2019-1 (1)
- 2019-2 (1)
- 2019-3 (1)
- 2019-4 (1)
- Introduction (4)
- R&D innovation (5)
- Sponsored features (6)
- Supporters (3)
- Uncategorized (2)